Study reveals the microbiota of people with genetic immune deficiency

A recent study analyzed microbial colonization in people with RAG deficiency to shed light on the effects of secondary immunodeficiencies.

Linking gut microbiota diversity to survival outcomes in children’s stem cell transplants

Results from a recent study suggest a correlation between the diversity and composition of the gut microbiota prior to transplantation and both the patient's survival and the probability of developing…

Mixture of milk sugars and live bacteria may restore damaged gut microbiotas

The findings of a recent study suggest that a mixture of B. infantis and HMOs can modulate the gut microbiota in adults.

Dietary intervention may change the microbiota, alleviate fatty liver disease

The findings of a recent study suggest that resistant-starch supplements can alter the gut microbiota in ways that alleviate NAFLD.

How physical activities shape our gut microbiome

Silvia Barbaresi, molecular biologist, researcher and nutritionist at Ghent Univerity, discusses how sports and physical activity in general impact on gut microbiota composition.

Boehringer Ingelheim acquires T3 Pharma, boosting immuno-oncology efforts

In a significant move to expand its immuno-oncology portfolio, Boehringer Ingelheim has acquired T3 Pharmaceuticals AG, a Swiss biotech company specializing in bacterial cancer therapy.

In silico trials: the avant-garde of clinical trials in support of Biofarma Group’s product Epatrex

Epatrex, a new nutraceutical compound formulated as a three-layer tablet containing the probiotic Lactobacillus casei LC-XCAL.

Socio-economic adversities are associated with gut microbiota alterations

Microbial differences may help to identify targets that could be modulated to mitigate health inequities.

The impact of gut bacteria on micronutrient status in the host

The interplay between micronutrients and the microbiome is a significant factor in determining the risk of vitamin and mineral deficiencies, which has implications for global public health.

Unraveling the gut microbiome’s role in celiac disease pathogenesis

Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, discusses how celiac disease could become a model to study the link between gut microbiome and disease pathogenesis.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top